| (HKD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | 177.03M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Year to date, 2637.HK has returned +47.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +47.9% |
| All-time high | $261.00 (Apr 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in 2637.HK would be worth today ›No. Fujian Haixi Pharmaceuticals Co., Ltd. has not paid a dividend in the past 12 months.
Fujian Haixi Pharmaceuticals Co., Ltd. is part of the Healthcare sector.
Fujian Haixi Pharmaceuticals Co., Ltd. has a market cap of 15.26B HKD, based on the latest quote.
